Webjcog1109試験は、切除可能な局所進行扁平上皮食道癌における、術前cf療法に対する術前dcf療法と術前cf+rt療法の優越性を検証した、国内無作為化比較第iii相試験であり、本 … Web25 gen 2024 · Dr Ken Kato speaks to ecancer about the JCOG1109 NExT study which is a randomised controlled phase III trial comparing two chemotherapy regimens and chemoradiotherapy regimens as neoadjuvant treatment for locally advanced oesophageal cancer. He initially, talks about the background and methodology of the study.
DCF outperforms standard-of-care for locally advanced …
Web5 feb 2015 · Chemotherapy with cisplatin plus fluorouracil is the current standard treatment for metastatic or recurrent esophageal cancer. We have developed a 2-weekly docetaxel combined with CF regimen and conducted a Phase I/II trial for metastatic or recurrent esophageal cancer (JCOG0807). Promising efficacy … WebBackground: JCOG1109 trial, which assessed the superiority of DCF over CF, and the superiority of chemoradiotherapy with CF over CF alone demonstrated the significant … how to get to the registry editor
292. ROLE OF PREOPERATIVE NEOADJUVANT …
WebAffiliations 1 Department of Gastric Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, chuo-ku, Tokyo, 104-0045, Japan. [email protected].; 2 Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.; 3 Department of Surgery, Yokohama City University, Yokohama, Japan.; 4 Department of … Web8 apr 2024 · Triplet NAC with docetaxel plus CF has become the new standard, on the basis of results of the JCOG1109 trial [14, 15]. Nevertheless, other neoadjuvant regimens, such as nedaplatin (a platinum derivative) plus 5-fluorouracil, doxorubicin (adriamycin) plus CF, CF plus radiotherapy, and docetaxel plus CF plus radiotherapy, were utilized at the … WebA randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal … john short supercross